William John Sibold - President and CEO, Director at Madrigal Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
MDGL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by William John Sibold since 8/27/2023

Holdings reported by William John Sibold for Madrigal Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 62.3K $15.2M $243.92 Jan 23, 2024 Direct
Market Stock Unit 12.3K $2.99M $243.92 Jan 23, 2024 Direct Common Stock
Performance Restricted Stock Units 50K Sep 11, 2023 Direct Common Stock
Stock Option (Right to Buy) 18.5K Jan 23, 2024 Direct Common Stock

Transactions reported by William John Sibold for Madrigal Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.